Cialis C 100 - Buy cialis Online

Mc Mimo Ft Viagra


Mc Mimo Ft Viagra Mc Mimo Ft Viagra

Azithromycin Zithromax Suspension


Azithromycin Zithromax Suspension Azithromycin Zithromax Suspension

Cytotec Nayarit


Cytotec Nayarit Cytotec Nayarit

Accutane Results When


Accutane Results When Accutane Results When

Ciprofloxacin Logo


Ciprofloxacin Logo Ciprofloxacin Logo


will cialis help me ejaculate
cialis commercial notes
what is the expiration time of cialis
erfahrungsberichte zu cialis
is cialis used for enlarged prostate
discount 2.5 cialis
cialis is vey expensive
dosis correcta cialis
cialis deflate parody
generic cialis aurochem reviews
higher dose cialis
tempat jual cialis
cialis on line paying by paypal
cialis tales
name of the company make cialis
why bathtub cialis
where can i get cialis in australia
buy cialis berlin
cost of cialis in australia legal
cialis hard on
cialis i prezzi
media cialis hace efecto
directions for takiing cialis
difference between effectiveness cialis 10 mg and 20
cialis food taking
cialis official
cialis e20 pill
cialis 800mg comer antes
comparatif cialis kamagra
discount cialis
remedio cialis 20mg
cialis buy cialis online order cialis
ron paul obama is a corporatist not a socialist
can you halve cialis
cialis bitkisel mi

CoMentis, Inc. is focused on the research and development of small molecule drugs to treat CNS disorders. The company, with headquarters in South San Francisco, was founded based on the groundbreaking discoveries on structure, function, and inhibition of the beta-secretase enzyme by Jordan Tang, Ph.D., J.G. Puterbaugh Chair in Biomedical Research at the Oklahoma Medical Research Foundation and Arun K. Ghosh, Ph.D., Ian P. Rothwell Distinguished Professor - Organic Chemistry/Medicinal Chemistry at Purdue University.

CoMentis is developing an orally administered disease-modifying treatment for Alzheimer's disease that inhibits the beta-secretase enzyme to reduce the formation of beta amyloid peptides, thereby preventing deleterious effects of accumulated amyloid peptides and downstream pathologies.  Beta amyloid peptides aggregate to form soluble polymers and insoluble plaques in the brain, implicated in the development of Alzheimer's disease.  Inhibition of beta-secretase reduces amyloid beta production and could block the progression of Alzheimer's disease.

CoMentis is currently pursuing the development of beta-secretase inhibitor drugs in partnership with Astellas Pharma, Inc., under terms of an exclusive worldwide collaboration agreement initiated in 2008.